iNCOVACC (codenamed BBV154) is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, American company Precision Virologics and the Washington...
7 KB (429 words) - 18:06, 29 November 2023
the PLA Academy of Military Science. Full (0) Emergency (1) Indonesia iNCOVACC, also called BBV154 is an adenovirus vector vaccine developed by Bharat...
319 KB (19,375 words) - 22:21, 17 July 2024
September 2022, India and China approved two nasal COVID‑19 vaccines (iNCOVACC and Convidecia), which may (as boosters) also reduce transmission (potentially...
198 KB (22,632 words) - 22:28, 17 July 2024
royalty from Covaxin sales. INCOVACC COVID-19 (virus SARS-CoV-2) Bharat Biotech/Indian Council of Medical Research Completed iNCOVACC (codenamed BBV154) is...
166 KB (5,145 words) - 16:06, 22 July 2024
AdCLD-CoV19 BriLife COH04S1 DelNS1-2019-nCoV-RBD-OPT GRAd-COV2 ImmunityBio iNCOVACC INNA-051 NDV-HXP-S Vaxart COVID-19 vaccine Virus-like particles ABNCoV2...
180 KB (23,901 words) - 19:16, 17 June 2024
Covaxin, a whole-inactivated-virus-based vaccine delivered by injection iNCOVACC, an adenovirus vectored intranasal COVID-19 vaccine This disambiguation...
242 bytes (67 words) - 21:19, 14 September 2023
vaccines have been developed with the onset of the COVID-19 pandemic. inCOVACC, Razi Cov Pars, Sputnik, and Convidicia are nasal COVID-19 vaccines that...
29 KB (3,397 words) - 17:20, 29 September 2023
(15+), Corbevax (12-14), Sputnik V (18+),Corbevax (12-14), Gemcovac (18+) Incovacc (18+), ZyCoV-D (18+) and Covovax (12+). In the future, the Health ministry...
15 KB (1,426 words) - 11:07, 23 February 2024
Sputnik Light, Sputnik V, Oxford–AstraZeneca, Convidecia, Janssen, and iNCOVACC sixteen subunit vaccines: Abdala, Corbevax, COVAX-19, EpiVacCorona, IndoVac...
95 KB (18,965 words) - 15:46, 23 June 2024